By Wolfgang Hackl M.D., Founder & CEO, OncoGenomX Inc., Switzerland During my career as an oncologist and cancer drug developer, one question haunted me more than...
AI technology can identify 42 per cent of breast cancers that develop between routine mammograms by flagging women at highest risk, researchers have found. The study...
Long-term exposure to air pollution may increase the risk of breast cancer, with a study of more than 400,000 women showing higher rates in areas with...
Just one in five women with breast or cervical cancer in low- and middle-income countries are diagnosed early, compared with more than one in three in...
Women who breastfeed develop protective immune cells that help guard against breast cancer, with effects lasting for more than 30 years, new research shows. The study...
Co-written By Dr Claire Gillvray and Tarang Majmudar, Welbeck Cambridge (2026) Gynaecological cancers, cervical, ovarian, uterine, vaginal, and vulvar, pose a significant health risk across all...
Whole genome sequencing could identify unique genetic features to guide treatment for more than 15,000 breast cancer patients each year in the UK, new research suggests....
A targeted therapy has improved survival compared with chemotherapy in patients with triple-negative breast cancer who cannot receive immunotherapy. The drug, an antibody-drug conjugate (a treatment...
High-risk women can now delay ovary removal surgery through NHS screening, helping them preserve fertility and avoid early surgical menopause. The ROCA test tracks women with...
A large, long-term study has found that the introduction of the human papillomavirus (HPV) vaccine in community settings is highly effective in protecting young women from...
